Caribou Biosciences, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 2.59M | $4.92M | 0.01% | Added+58.0% | 2026-03-31 |
| TwoSigma | quant | 1.76M | $3.34M | 0.00% | Added+72.5% | 2026-03-31 |
| FidelityFMR | fundamental | 724.0K | $1.38M | 0.00% | Unchanged | 2026-03-31 |
| StateStreet | passive | 423.3K | $804.20K | 0.00% | Unchanged | 2026-03-31 |
| Citadel | multi-strat | 187.6K | $356.48K | 0.00% | Trimmed-53.6% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.31 | — | — |
| 2026-05-07 | -0.31 | -0.26 | +16.13% |
| 2026-03-05 | -0.32 | -0.28 | +12.89% |
| 2025-11-12 | -0.36 | -0.30 | +15.95% |
| 2025-08-12 | -0.42 | -0.35 | +16.67% |
| 2025-05-08 | -0.44 | -0.44 | +2.22% |
| 2025-03-10 | -0.40 | -0.39 | +3.28% |
| 2024-11-06 | -0.45 | -0.38 | +15.10% |
| 2024-08-06 | -0.44 | -0.44 | +0.91% |
| 2024-05-07 | -0.38 | -0.47 | -21.33% |
| 2024-03-11 | -0.35 | -0.41 | -15.48% |
| 2023-11-07 | -0.36 | -0.12 | +67.31% |
| 2023-08-08 | -0.48 | -0.49 | -1.15% |
| 2023-05-09 | -0.49 | -0.46 | +5.65% |
| 2023-03-09 | -0.47 | -0.46 | +1.23% |
| 2022-11-08 | -0.48 | -0.44 | +8.90% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| CRBU | +26.20% | +34.09% | +48.43% | +122.64% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +23.23% | +38.73% | +51.87% | +109.95% |